THE UNPRECEDENTED COVID-19 EFFECT: SECONDARY TRAUMA IN PATIENTS & STRATEGIES FOR CLINICAL PRACTICE

Abstract Whether one is a new graduate from nursing school, a skilled veteran of many crises, or well-versed in trauma, the need to understand COVID-19 secondary trauma cannot be overstated. It reflects on our daily lives, with the flow into our workplaces. Dealing with another’s suffering is not something that most (except a noticeable few) have been trained for. When it comes to communication, many rely on spoken language at the expense of the rest of our communication toolbox. People suffering secondary trauma might withdraw or be resigned to bad behavior to avoid physical harm. One way to support people with secondary trauma stress is through mindfulness techniques based on trauma-sensitive care. There are simple ways healthcare workers can help patients become calm, help connect, and communicate more effectively with others. The purpose of this paper is to provide clinical practice strategies for secondary trauma in patients

THE UNPRECEDENTED COVID-19 EFFECT: SECONDARY TRAUMA IN PATIENTS & STRATEGIES FOR CLINICAL PRACTICE

Abstract Whether one is a new graduate from nursing school, a skilled veteran of many crises, or well-versed in trauma, the need to understand COVID-19 secondary trauma cannot be overstated. It reflects on our daily lives, with the flow into our workplaces. Dealing with another’s suffering is not something that most (except a noticeable few) have been trained for. When it comes to communication, many rely on spoken language at the expense of the rest of our communication toolbox. People suffering secondary trauma might withdraw or be resigned to bad behavior to avoid physical harm. One way to support people with secondary trauma stress is through mindfulness techniques based on trauma-sensitive care. There are simple ways healthcare workers can help patients become calm, help connect, and communicate more effectively with others. The purpose of this paper is to provide clinical practice strategies for secondary trauma in patients

Lung cancer and kidney injury: An updated review

Lung cancer is the leading cause of cancer deaths worldwide, accounting for an estimated 1.8 million deaths. Lung cancer is also the most common primary cancer leading to soft tissue (ST) metastasis. Renal disease may occur as a direct or indirect consequence of the cancer itself (e.g., post-renal obstruction, compression, or infiltration), its treatment (e.g., radiotherapy or chemotherapy), or its related complications (e.g., opportunistic infection). Existing evidence shows that the most frequent primary solid tumor responsible for renal metastasis is pulmonary carcinoma, followed by gastric, breast, soft tissue, and thyroid carcinomas. Chronic kidney disease is a potential risk factor in the survival of patients with lung cancer. In this review, we will discuss causes of kidney injury in relation to lung cancer, potential mechanisms of kidney injury, and treatment options. © 2021 The Author(s); Published by Society of Diabetic Nephropathy Prevention.Open access journalThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at [email protected]

The ferric conundrum: which intravenous iron preparations are preferred for chronic kidney disease patients?

Implication for health policy/practice/research/medical education: It has been demonstrated that iron deposition in the kidney is a harbinger of poor prognosis, but it is not clear whether kidney failure/damage predisposes iron deposition, or iron deposition activates an oxidative cascade and causes kidney damage. Until this issue is clarified, it will be difficult to predict the risks or benefits of any iron infusion for chronic kidney disease. © 2022 The Author(s).Open access journalThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at [email protected]

Seasonal variation of vitamin D in patients on hemodialysis

Background: Seasonal and racial differences in serum 25-hydroxyvitamin D levels have been studied extensively in the general population but not in patients with end-stage renal disease (ESRD) Methods Serum 25-hydroxyvitamin D levels, the best available index of vitamin D nutrition, was measured at the end of summer (September) in 142 chronic hemodialysis patients and again at the end of winter (April) in 73 of these 142 patients, to determine the prevalence and risk factors for vitamin D deficiency Results. The prevalence of vitamin D depletion, as defined by serum 25-hydroxyvitamin D level of less than 20 ng/ml (50 nmol/l), was 54% at the end of summer and further increased to 86% by the end of winter (p < 0 0001 summer vs winter). We observed that women and African-Americans had a greater prevalence of hypovitaminosis D (p < 0.0002 and p < 0 001 for both comparisons, respectively). Surprisingly, diabetic status, age, and the duration of ESRD were not associated with a significant increase in risk of vitamin D depletion Conclusion Vitamin D depletion is present in about half of ESRD patients with marked seasonal variations Patients with ESRD should have more frequent assessments of their vitamin D nutrition by serum 25-hydroxyvitamin D levels, and vitamin D supplementation should be routinely prescribed, which may prevent many of the complications related to vitamin D deficiency and secondary hyperparathyroidism